Percutaneous fetal sclerotherapy for congenital cystic adenomatoid malformation of the lung

Fetal Diagnosis and Therapy

Volumn 24, Issue 3, 2008, Pages 237-240

  Bermúdez, Carlos ^a   Pérez Wulff, Juan ^a   Arcadipane, Mauricio ^a   Bufalino, Gesualdo ^a   Gómez, Libardo ^a   Flores, Luis ^a   Sosa, Cristian ^a   Bornick, Patricia W ^b   Kontopoulos, Eftichia ^b   Quintero, Rubén A ^b  

^a HOSPITAL UNIVERSITARIO DE CARACAS   (Venezuela)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Cystic congenital adenomatoid malformation; Ethamolin (ethanolamine oleate); Fetal hydrops; Fetal therapy; Lung mass; Polidocanol (aethoxysklerol); Ultrasound

Indexed keywords

ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CYSTIC ADENOMATOID MALFORMATION; FETUS ELECTROCARDIOGRAPHY; FETUS HYDROPS; GESTATIONAL AGE; HUMAN; HYDRAMNIOS; NEWBORN; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY DISTRESS; SCLEROTHERAPY; TUBE;

ADULT; CYSTIC ADENOMATOID MALFORMATION OF LUNG, CONGENITAL; FEMALE; FETAL DISEASES; GESTATIONAL AGE; HUMANS; HYDROPS FETALIS; PREGNANCY; SCLEROTHERAPY; ULTRASONOGRAPHY, PRENATAL;

EID: 50049125834     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000151345     Document Type: Article

References (21)

1. Stocker JT, Madewell JE, Drake RM: Congenital cystic adenomatoid malformation of the lung: classification and morphologic spectrum. Hum Pathol 1977;8:155-171.
2. Gornall AS, Budd JL, Draper ES, Konje JC, Kurinczuk JJ: Congenital cystic adenomatoid malformation: accuracy of prenatal diagnosis, prevalence and outcome in a general population. Prenat Diagn 2003;23:997-1002.
3. Adzick NS, Flake AW, Crombleholme TM: Management of congenital lung lesions. Semin Pediatr Surg 2003;12:10-16.
4. Illanes S, Hunter A, Evans M, Cusick E, Soothill P: Prenatal diagnosis of echogenic lung: evolution and outcome. Ultrasound Obstet Gynecol 2005;26:145-149.
5. Askin FB, Gilbert-Barness E: Respiratory system; in Gilbert-Barness E (ed): Potter's Pathology of the Fetus, Infant and Child. Philadelphia, Mosby Elsevier, 2007, vol 2, pp 1108-1109.
6. Evrard V, Ceulemans J, Coosemans W, De Baere T, De Leyn P, Deneffe G, Devlieger H, De Boeck C, Van Raemdonck D, Lerut T: Congenital parenchymatous malformations of the lung. World J Surg 1999;23:1123-1132.
7. Barnes NA, Pilling DW: Bronchopulmonary foregut malformations: embryology, radiology and quandary. Eur Radiol 2003;13:2659-2673.
8. Bale PM: Congenital cystic malformation of the lung: a form of congenital bronchiolar ('adenomatoid') malformation. Am J Clin Pathol 1979;71:411-420.
9. Thorpe-Beeston JG, Nicolaides KH: Cystic adenomatoid malformation of the lung: prenatal diagnosis and outcome. Prenat Diagn 1994;14:677-688.
10. Kunisaki SM, Barnewolt CE, Estroff JA, Ward VL, Nemes LP, Fauza DO, Jennings RW: Large fetal congenital cystic adenomatoid malformations: growth trends and patient survival. J Pediatr Surg 2007;42:404-410.
11. Paterson A: Imaging evaluation of congenital lung abnormalities in infants and children. Radiol Clin N Am 2005;43:303-323.
12. Wilson RD, Baxter JK, Johnson MP, King M, Kasperski S, Crombleholme TM, Flake AW, Hedrick HL, Howell LJ, Adzick NS: Thoracoamniotic shunts: fetal treatment of pleural effusions and congenital cystic adenomatoid malformations. Fetal Diag Ther 2004;19:413-420.
13. Harrison MR, Adzick NS, Jennings RW, Duncan BW, Rosen MA, Filly RA, Goldberg JD, DeLorimier AA, Golbus MS: Antenatal intervention for congenital cystic adenomatoid malformation. Lancet 1990;336:965-967.
14. Bruner JP, Jarnagin BK, Reinisch L: Percutaneous laser ablation of fetal congenital cystic adenomatoid malformation: too little, too late? Fetal Diag Ther 2000;15:359-363.
15. Bermudez C, Perez-Wulff J, Bufalino G, Sosa C, Gomez L, Quintero RA: Percutaneous ultrasound-guided sclerotherapy for complicated fetal intralobar bronchopulmonary sequestration. Ultrasound Obstet Gynecol 2007;29:586-589.
16. Yamamoto K, Sakaguchi H, Anai H, Tanaka T, Morimoto K, Kichikawa K, Uchida H: Sclerotherapy for simple cysts with use of ethanolamine oleate: preliminary experience. Cardiovasc Intervent Radiol 2005;28:751-755.
17. Naik MN, Murthy RK, Raizada K, Honavar SG: Ethanolamine oleate sclerotherapy in the management of orbito-palpebral cyst associated with congenital microphthalmos. Am J Ophthalmol 2005;139:939-941.
18. Brown B, Sharifi R, Lee M: Ethanolamine sclerotherapy of a renal cyst. J Urol 1995;153:385-386.
19. Tammela TL, Hellstrom PA, Mattila SI, Ottelin PJ, Malinen LJ, Makarainen HP: Ethanolamine oleate sclerotherapy for hydroceles and spermatoceles: a survey of 158 patients with ultrasound follow-up. J Urol 1992;147:1551-1553.
20. Hellstrom P, Tammela T, Kontturi M, Lukkarinen O: Ethanolamine oleate as a sclerosant for testicular hydroceles and epididymal cysts. Br J Urol 1988;62:445-448.
21. Hellstrom P, Malinen L, Kontturi M: Sclerotherapy for hydroceles and epididymal cysts with ethanolamine oleate. Ann Chir Gynaecol 1986;75:51-54.